Clinical Trial: Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers

Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers


Sponsor and Collaborators
National University Hospital, Singapore

Contact
National University Hospital Recruiting
Singapore, Singapore
Contact: Ross Andrew Soo, MBBS 65-6772-4624 Ross_Soo@nuh.com.sg
Sub-Investigator: Salto-Tellez Manuel

Principal Investigator
Ross Andrew Soo, MBBS
National University Hospital, Singapore

Alex Chang
Johns Hopkins Singapore International Medical Centre

Chung Yip Chan
Tan Tock Seng Hospital

Clinical Trials.gov Identifier
NCT00716209
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs